Details van artikel 121 van 186 gevonden artikelen
Phase 1/2 Study of Ap26113 in Patients (PTS) with Advanced Malignancies, Including Anaplastic Lymphoma Kinase (ALK)–Positive Non-Small Cell Lung Cancer (NSCLC): Analysis of Safety and Efficacy at Selected Phase 2 Doses
Titel:
Phase 1/2 Study of Ap26113 in Patients (PTS) with Advanced Malignancies, Including Anaplastic Lymphoma Kinase (ALK)–Positive Non-Small Cell Lung Cancer (NSCLC): Analysis of Safety and Efficacy at Selected Phase 2 Doses
Auteur:
Rosell, R. Gettinger, S. Bazhenova, L.A. Langer, C.J. Salgia, R. Gold, K. Shaw, A.T. Dorer, D.J. Kerstein, D. Camidge, D.R.
Verschenen in:
Annals of oncology
Paginering:
Jaargang 26 () nr. S1 pagina's i29
Jaar:
2015
Inhoud:
Uitgever:
European Society for Medical Oncology
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 121 van 186 gevonden artikelen